Piramal Pharma Limited Announces Results for Q2 and H1 FY25 Oct 23, 2024 02:01PM
Piramal Pharma releases its Sustainability Report for FY 2023-24 under the theme, 'Building Resilience for a Sustainable Tomorrow' Oct 4, 2024 06:43AM
Piramal Pharma Solutions Announces $80M Expansion Plan for Sterile Injectables Facility in Lexington, Kentucky Sep 30, 2024 10:35AM
Piramal Pharma's GHG Commitment Validated and Approved by SBTi Sep 16, 2024 08:43AM
Piramal Pharma Solutions Achieves Revenue Threshold on Innovation Work Jul 30, 2024 07:55AM


Jul 26, 2024 06:45AM Piramal Pharma Limited Announces Consolidated Results for Q1FY25
Dec 18, 2023 04:10PM PIRAMAL PHARMA SOLUTIONS COMMEMORATES OPENING OF ITS ADC MANUFACTURING EXPANSION IN GRANGEMOUTH, SCOTLAND
Oct 28, 2023 07:09AM Piramal Pharma Limited Announces Consolidated Results for Q2 and H1 FY2024
Oct 17, 2023 02:34PM Piramal Pharma Solutions Launches In-Vitro Biology Capabilities at Ahmedabad Discovery Services Site
Aug 3, 2023 06:28PM Piramal Pharma Limited Announces Consolidated Results for Q1FY24
Jun 6, 2023 06:31AM Piramal Critical Care Appoints Jeffrey Hampton as President & Chief Operating Officer
May 24, 2023 04:49PM Piramal Pharma Limited Announces Consolidated Results for Q4 and FY2023
May 2, 2023 07:00AM Plus Therapeutics Expands Collaboration with Piramal Pharma Solutions to Meet Increase in Investigational Drug Demand for Ongoing and Planned Clinical Trials
Mar 30, 2023 04:02AM PIRAMAL PHARMA SOLUTIONS SUPPORTS THERACOSBIO WITH INTEGRATED DRUG SUBSTANCE/DRUG PRODUCT PROGRAM FOR BEXAGLIFLOZIN
Feb 15, 2023 10:32AM PIRAMAL PHARMA SOLUTIONS ANNOUNCES PRODUCTION OF FIRST BATCHES AT NEW API FACILITY IN RIVERVIEW, MICHIGAN
Feb 8, 2023 03:17PM Piramal Pharma Limited Announces Consolidated Results for Q3 and 9M FY2023
Nov 17, 2022 08:31AM Piramal Critical Care (PCC) commits to reduce its environmental footprint and growing responsibly through sustainable operations
Nov 9, 2022 01:13AM Piramal Pharma Limited Announces Consolidated Results for Q2 and H1 FY2023